Baidu
map
VASC ENDOVASC SURG 润色咨询

Vascular and Endovascular Surgery

出版年份：2002 年文章数：1880 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：4.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2023-03-18 路漫漫其修远

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：外科
    经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    我没有认识的专家，不推荐可以吗？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    推荐同行评议时需要注意哪些情况？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-21 ms8000001327218017

    审稿速度:1.0 | 投稿命中率:95.0
    经验分享：10月投稿，一个多月返回小修，12月接受

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2018-05-16 1511ef4916m

    审稿速度:1.0
    经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-07-14 zhengxiaobing

    跨过一分大关,神仙保佑!!明年超过2分吧

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2120300, encodeId=4db42120300d6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：外科<br>经验分享：2月7日投稿了，5天后送外审，3月12日显示Awaiting Final Decision，一周了状态还是Awaiting Final Decision，请问这种情况接收概率大吗，等着毕业用，又怕催了直接给我拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=52465528704, createdName=路漫漫其修远, createdTime=Sat Mar 18 16:11:07 CST 2023, time=2023-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103273, encodeId=a35f11032e3cb, content=我没有认识的专家，不推荐可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103274, encodeId=cf1411032e443, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082579, encodeId=907f10825e94c, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：10月投稿，一个多月返回小修，12月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Tue Dec 21 14:48:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556096, encodeId=f2a855609675, content=审稿速度:1.0<br>经验分享：杂志不是很友好.外审two reviewers 一个没有评论.一个建议小修-然后直接被否决了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab02067095, createdName=1511ef4916m, createdTime=Wed May 16 00:00:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542010, encodeId=c8e5542010ab, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477620, encodeId=bed14e7620ea, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97bc29754, createdName=dq5183742, createdTime=Wed Jun 29 09:44:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 dq5183742

    偏重的研究方向：外科;

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map